BioCision to Develop Controlled-Rate Cell Freezing Systems for Cook Regentec Cell Therapy Vials

News   Jul 29, 2015

 
BioCision to Develop Controlled-Rate Cell Freezing Systems for Cook Regentec Cell Therapy Vials
 
 
 

RELATED ARTICLES

CRISPR Screening Reveals Sickle Cell Disease Target

News

A key signaling protein, known as heme-regulated inhibitor (HRI), has been identified as a potential therapeutic target for the development of drugs to treat sickle cell disease, using a CRISPR screening approach.

READ MORE

Novel Therapeutic Target for Breast Cancer

News

Research has shown for the first time that a tiny piece of RNA deregulates energy metabolism, an emerging hallmark of cancer. The finding identifies a new target for therapeutic intervention in breast cancer.

READ MORE

New Retinal Ganglion Cell Subtypes Emerge From Single-Cell RNA Sequencing

News

40 subtypes of retinal ganglion cells classified, raising questions about what constitutes a cell type or subtype

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy